Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Sales: 2013-2025

Historic Return on Sales for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to -1.21%.

  • Fortress Biotech's Return on Sales rose 69.00% to -1.21% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.21%, marking a year-over-year increase of 69.00%. This contributed to the annual value of -2.10% for FY2024, which is 27.00% down from last year.
  • As of Q3 2025, Fortress Biotech's Return on Sales stood at -1.21%, which was up 35.38% from -1.87% recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Return on Sales peaked at -1.21% during Q3 2025, and registered a low of -3.47% during Q2 2023.
  • For the 3-year period, Fortress Biotech's Return on Sales averaged around -2.03%, with its median value being -1.87% (2025).
  • As far as peak fluctuations go, Fortress Biotech's Return on Sales plummeted by 95bps in 2023, and later soared by 223bps in 2024.
  • Fortress Biotech's Return on Sales (Quarterly) stood at -2.69% in 2021, then fell by 9bps to -2.78% in 2022, then skyrocketed by 104bps to -1.74% in 2023, then dropped by 27bps to -2.01% in 2024, then spiked by 69bps to -1.21% in 2025.
  • Its last three reported values are -1.21% in Q3 2025, -1.87% for Q2 2025, and -1.77% during Q1 2025.